Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Mayne Pharma, a Salisbury South, Australia-headquartered pharmaceutical company reports that it and its contract development and manufacturing business, Metrics Contract Services, have opened a new $80-million, oral solid-dose commercial...

A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Roche. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday, April 11, 2017 to Tuesday,...

Novartis plans to invest more than $100 million to advance research and development (R&D) of treatments for malaria. The company also plans to implement an equitable pricing strategy to maximize patient access in malaria-endemic countries when...

Sanofi and Advent International, a Boston-based private-equity firm, have entered into negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for EUR 1.9 billion ($2.4 billion)​. Advent will work with Sanofi to...

Boehringer Ingelheim (BI) and Eli Lilly and Company have partnered in an academic collaboration with the University of Oxford to investigate the effects of the companies’ diabetes drug, Jardiance (empagliflozin), on the progression of kidney...

Shire has agreed to sell its oncology business to Servier, a Suresnes, France-based pharmaceutical company, for $2.4 billion. Shire’s oncology business includes in-market products, Oncaspar (pegaspargase), a component of a multi-agent treatment...

A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Bristol-Myers Squibb and Novartis. Editor's Note: This article was updated on a continuous basis for news announced from Wednesday April...

Bristol-Myers Squibb (BMS) and Illumina, a San Diego, California-headquartered company developing and commercializing systems for analysis of genetic variation and function, have partnered to use Illumina’s sequencing technology to develop and...